The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
Open accessAbstract
Cancer is a major health problem around the world. Research efforts in the last few decades have been successful in providing better and effective treatments against both early stage and localized cancer, but clinical options against advanced metastatic stage/s of cancer remain limited. The high morbidity and mortality in most of the cancers are attributed to their metastatic spread to distant organs. Due to its extreme clinical relevance, metastasis has been extensively studied and is now understood as a highly complex biological event that involves multiple steps including acquisition of invasiveness by cancer cells, intravasation into circulatory system, survival in the circulation, arrest in microvasculature, extravasation, and growth at distant organs. The increasing understanding of molecular underpinnings of these events has provided excellent opportunity to target metastasis especially through nontoxic and biologically effective nutraceuticals. Silibinin, a popular dietary supplement isolated from milk thistle seed extracts, is one such natural agent that has shown biological efficacy through pleiotropic mechanisms against a variety of cancers and is currently in clinical trials. Recent preclinical studies have also shown strong efficacy of silibinin to target cancer cell’s migratory and invasive characteristics as well as their ability to metastasize to distant organs. Detailed mechanistic analyses revealed that silibinin targets signaling molecules involved in the regulation of epithelial-to-mesenchymal transition, proteases activation, adhesion, motility, invasiveness as well as the supportive tumor-microenvironment components, thereby inhibiting metastasis. Overall, the long history of human use, remarkable nontoxicity, and preclinical efficacy strongly favor the clinical use of silibinin against advanced metastatic cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Agarwal, C., Tyagi, A., Kaur, M., & Agarwal, R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm042 · Cited by 129
Self-citationRetractedTyagi, A., Singh, R. P., Agarwal, C., & Agarwal, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl098 · Cited by 76
Self-citationRetractedGu, M., Dhanalakshmi, S., Mohan, S., Singh, R. P., & Agarwal, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi096 · Cited by 65
Self-citationRetractedJemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 3×
“This theory, which placed main emphasis on the compatibility between metastatic cancer cells and their microenvironment, was contested by James Ewing, who alternatively proposed that metastatic propensity of cancer cells is mostly dictated by circulatory patterns, and that metastasizing cancer cells would settle in or…”
BackgroundDissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
CA: A Cancer Journal for Clinicians
(2010) · CA A Cancer Journal for Clinicians · doi:10.3322/(issn)1542-4863 · Cited by 2,538
THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES
Batson, O. V. (1940) · Annals of Surgery · doi:10.1097/00000658-194007000-00016 · Cited by 1,922
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
INDIAN JOURNAL OF MEDICAL RESEARCH.
(1931) · The Lancet · doi:10.1016/s0140-6736(00)82268-0 · Cited by 1,632
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Cancer epidemiology biomarkers & prevention
Press, H. (1991) · Cited by 1,398
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
MAP kinases and cell migration
Huang, C., Jacobson, K., & Schaller, M. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01481 · Cited by 1,074
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
Roy, R., Yang, J., & Moses, M. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5556 · Cited by 854
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt, B., Hafner, M., Echtenacher, B., & Männel, D. N. (1999) · PubMed · Cited by 832
Journal of the National Cancer Institute
(1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1387 · Cited by 832
Genetic determinants of cancer metastasis
Nguyen, D. X., & Massagué, J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2101 · Cited by 801
The role of epithelial-mesenchymal transition in cancer pathology
guarino, M., rubino, B., & ballabio, G. (2007) · Pathology · doi:10.1080/00313020701329914 · Cited by 790
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M., & Mareel, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 695
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan, S. C., & Girish, C. (2006) · PubMed · Cited by 516
Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B., & Farrar, W. L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604242 · Cited by 437
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
CLINICAL STUDIES WITH CURCUMIN
Hsu, C.-H., & Cheng, A.-L. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_21 · Cited by 398
Calorie restriction and cancer prevention: metabolic and molecular mechanisms
Longo, V. D., & Fontana, L. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.004 · Cited by 378
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats
YANYU, X., YUNMEI, S., ZHIPENG, C., & QINENG, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.001 · Cited by 355
Tyagi, A. K., Singh, R. P., Agarwal, C., Chan, D. C. F., & Agarwal, R. (2002) · PubMed · Cited by 323
Self-citationA phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Self-citationPalumbo, J. S., Talmage, K. E., Massari, J. V., La Jeunesse, C. M., Flick, M. J., Kombrinck, K. W., Hu, Z., Barney, K. A., & Degen, J. L. (2007) · Blood · doi:10.1182/blood-2007-01-065995 · Cited by 312
Experimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
Kidd, P. M. (2009) · PubMed · Cited by 304
Anticancer potential of silymarin: from bench to bed side.
Agarwal, R., Agarwal, C., Ichikawa, H., Singh, R. P., & Aggarwal, B. B. (2006) · PubMed · Cited by 299
Self-citationTomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials
Basu, A., & Imrhan, V (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602510 · Cited by 279
Basal epithelial stem cells are efficient targets for prostate cancer initiation
Lawson, D. A., Zong, Y., Memarzadeh, S., Xin, L., Huang, J., & Witte, O. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913873107 · Cited by 275
Potential of Spice-Derived Phytochemicals for Cancer Prevention
Aggarwal, B., Kunnumakkara, A., Harikumar, K., Tharakan, S., Sung, B., & Anand, P. (2008) · Planta Medica · doi:10.1055/s-2008-1074578 · Cited by 269
Kidd, P. M., & Head, K. A. (2005) · PubMed · Cited by 253
Zi, X., & Agarwal, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7490 · Cited by 235
Self-citationMolecular mechanisms controlling E-cadherin expression in breast cancer
Baranwal, S., & Alahari, S. K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.051 · Cited by 230
Agarwal, C., Singh, R. P., Dhanalakshmi, S., Tyagi, A. K., Tecklenburg, M., Sclafani, R. A., & Agarwal, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207158 · Cited by 226
Self-citationKlarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., Thomas, S. B., & Farrar, W. L. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9242-2 · Cited by 221
Davis-Searles, P. R., Nakanishi, Y., Kim, N.-C., Graf, T. N., Oberlies, N. H., Wani, M. C., Wall, M. E., Agarwal, R., & Kroll, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4662 · Cited by 218
Self-citationJiang, Y., Luo, Y., He, D., Li, X., Zhang, L., Peng, T., Li, M., & Lin, Y. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01866.x · Cited by 217
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
Demicheli, R., Retsky, M. W., Hrushesky, W. J., & Baum, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0999 · Cited by 205
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 203
Deep, G., Singh, R. P., Agarwal, C., Kroll, D. J., & Agarwal, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209146 · Cited by 198
Self-citationFlaig, T. W., Glodé, M., Gustafson, D., van Bokhoven, A., Tao, Y., Wilson, S., Su, L., Li, Y., Harrison, G., Agarwal, R., et al. (2010) · The Prostate · doi:10.1002/pros.21118 · Cited by 193
Self-citationFlavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer
Hogan, F. S., Krishnegowda, N. K., Mikhailova, M., & Kahlenberg, M. S. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.080 · Cited by 191
Singh, R. P., Dhanalakshmi, S., Tyagi, A. K., Chan, D. C. F., Agarwal, C., & Agarwal, R. (2002) · PubMed · Cited by 191
Self-citationPress, H. (2001) · Cited by 190
Cancer stemness and metastasis: Therapeutic consequences and perspectives
Monteiro, J., & Fodde, R. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.030 · Cited by 186
García-Maceira, P., & Mateo, J. (2009) · Oncogene · doi:10.1038/onc.2008.398 · Cited by 185
Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways
Chen, P.-N., Hsieh, Y.-S., Chiou, H.-L., & Chu, S.-C. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.08.005 · Cited by 180
Silibinin Inhibits Colorectal Cancer Growth by Inhibiting Tumor Cell Proliferation and Angiogenesis
Singh, R. P., Gu, M., & Agarwal, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6247 · Cited by 177
Self-citationAdvances in the Use of Milk Thistle (Silybum marianum)
Post-White, J., Ladas, E. J., & Kelly, K. M. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301632 · Cited by 176
Chu, S., Chiou, H., Chen, P., Yang, S., & Hsieh, Y. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20018 · Cited by 176
Wen, Z., Dumas, T. E., Schrieber, S. J., Hawke, R. L., Fried, M. W., & Smith, P. C. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017566 · Cited by 172
Wu, W.-S., Wu, J.-R., & Hu, C.-T. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9112-4 · Cited by 171
Zhao, J., & Agarwal, R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2101 · Cited by 171
Self-citationMetastasis of cancer: a conceptual history from antiquity to the 1990s.
Weiss, L. (2000) · PubMed · Cited by 169
Bhatia, N., Zhao, J., Wolf, D. M., & Agarwal, R. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00276-1 · Cited by 169
Self-citationCancer metastasis: A product of tumor-host interactions
Sugarbaker, E. V. (1979) · Current Problems in Cancer · doi:10.1016/s0147-0272(79)80008-2 · Cited by 167
Osteotropic cancers: From primary tumor to bone
Buijs, J. T., & van der Pluijm, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.044 · Cited by 167
Hoh, C., Boocock, D., Marczylo, T., Singh, R., Berry, D. P., Dennison, A. R., Hemingway, D., Miller, A., West, K., Euden, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2724 · Cited by 166
Effect of Silibinin on the Growth and Progression of Primary Lung Tumors in Mice
Singh, R. P., Deep, G., Chittezhath, M., Kaur, M., Dwyer-Nield, L. D., Malkinson, A. M., & Agarwal, R. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj231 · Cited by 165
Self-citationZi, X., Feyes, D. K., & Agarwal, R. (1998) · PubMed · Cited by 164
Self-citationSingh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1309 · Cited by 161
Self-citationTyagi, A., Agarwal, C., Chan, D., & Agarwal, R. (2004) · Oncology Reports · doi:10.3892/or.11.2.493 · Cited by 158
Self-citationDhanalakshmi, S., Singh, R. P., Agarwal, C., & Agarwal, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205240 · Cited by 154
Self-citationGu, M., Dhanalakshmi, S., Singh, R. P., Agarwal, C., & Agarwal, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1632 · Cited by 151
Self-citationSingh, R. P., Tyagi, A. K., Zhao, J., & Agarwal, R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.499 · Cited by 150
Self-citationGu, M., Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3955 · Cited by 149
Self-citationProstate cancer chemoprevention by silibinin: Bench to bedside
Singh, R. P., & Agarwal, R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20223 · Cited by 147
Self-citationSilibinin Efficacy against Human Hepatocellular Carcinoma
Varghese, L., Agarwal, C., Tyagi, A., Singh, R. P., & Agarwal, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1646 · Cited by 146
Self-citationTyagi, A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh180 · Cited by 144
Silletti, S., Yebra, M., Perez, B., Cirulli, V., McMahon, M., & Montgomery, A. M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404075200 · Cited by 140
Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208276 · Cited by 139
Self-citationProposal for a new model of breast cancer metastatic development
Demicheli, R., Retsky, M. W., Swartzendruber, D. E., & Bonadonna, G. (1997) · Annals of Oncology · doi:10.1023/a:1008263116022 · Cited by 139
Prostate Cancer Prevention by Silibinin
Singh, R. P., & Agarwal, R. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481605 · Cited by 136
Self-citationSingh, R. P., Gu, M., Sharma, G. D., Dhanalakshmi, S., Tyagi, A. K., Chan, D. C. F., Agarwal, C., & Agarwal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1435 · Cited by 131
Self-citationRoy, S., Kaur, M., Agarwal, C., Tecklenburg, M., Sclafani, R. A., & Agarwal, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0104 · Cited by 131
Self-citationSon, Y.-G., Kim, E. H., Kim, J. Y., Kim, S. U., Kwon, T. K., Yoon, A. R., Yun, C., & Choi, K. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0407 · Cited by 130
Singh, R. P., Sharma, G. D., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2003) · PubMed · Cited by 127
Self-citationZi, X., Zhang, J., Agarwal, R., & Pollak, M. (2000) · PubMed · Cited by 126
Self-citationZhu, W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1399 · Cited by 124
Nutraceuticals and prostate cancer prevention: a current review
Trottier, G., Boström, P. J., Lawrentschuk, N., & Fleshner, N. E. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.234 · Cited by 122
Dynamic process of prostate cancer metastasis to bone
Tantivejkul, K., Kalikin, L. M., & Pienta, K. J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10664 · Cited by 121
Hsieh, Y., Chu, S., Yang, S., Chen, P.-N., Liu, Y.-C., & Lu, K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl221 · Cited by 121
Mechanisms of bone metastasis in prostate cancer: clinical implications
Msaouel, P., Pissimissis, N., Halapas, A., & Koutsilieris, M. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.011 · Cited by 120
Tyagi, A., Singh, R. P., Ramasamy, K., Raina, K., Redente, E. F., Dwyer‐Nield, L. D., Radcliffe, R. A., Malkinson, A. M., & Agarwal, R. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0095 · Cited by 120
Self-citationIn vitro and in vivo assessment of herb drug interactions
Venkataramanan, R., Komoroski, B. J., & Strom, S. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.021 · Cited by 118
Observations on the Antiquity of Cancer and Metastasis
Weiss, L. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1010646304844 · Cited by 116
Silibinin Inhibits Invasion of Oral Cancer Cells by Suppressing the MAPK Pathway
Chen, P.-N., Hsieh, Y., Chiang, C.-L., Chiou, H. L., Yang, S., & Chu, S. (2006) · Journal of Dental Research · doi:10.1177/154405910608500303 · Cited by 113
Identifying Site-specific Metastasis Genes and FunctionsPreprint
Gupta, G. P., Minn, A. J., Kang, Y., Siegel, P. M., Serganova, I. S., Cordon‐Cardo, C., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.018 · Cited by 111
Kaur, M., Balaiya, V., Tyagi, A., Agarwal, C., Singh, R. P., & Agarwal, R. (2010) · Neoplasia · doi:10.1593/neo.10188 · Cited by 110
Self-citationWu, K., Zeng, J., Zhu, G., Zhang, L., Zhang, D., Li, L., Fan, J., Wang, X., & He, D. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.94 · Cited by 110
Dhanalakshmi, S., Mallikarjuna, G. U., Singh, R. P., & Agarwal, R. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh152 · Cited by 105
Self-citationScambia, G., Vincenzo, R. D., Ranelletti, P. O., Panici, P. B., Ferrandina, G., D’Agostino, G. R., Fattorossi, A., Bombardelli, E., & Mancuso, S. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00011-1 · Cited by 103
Mateen, S., Tyagi, A., Agarwal, C., Singh, R. P., & Agarwal, R. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20595 · Cited by 102
Self-citationEffects and mechanisms of silibinin on human hepatoma cell lines
Lah, J. J., Cui, W., & Hu, K.-Q. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i40.5299 · Cited by 100
In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery
Wang, Y., Zhang, D., Liu, Z., Liu, G., Duan, C., Jia, L., Feng, F., Zhang, X., Shi, Y., & Zhang, Q. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/15/155104 · Cited by 100
Anti-angiogenic effect of silymarin on colon cancer lovo cell line
Yang, S.-H., Lin, J.-K., Chen, W.-S., & Chiu, J. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00229-4 · Cited by 99
Danilenko, M., Wang, Q., Wang, X., Levy, J., Sharoni, Y., & Studzinski, G. P. (2003) · PubMed · Cited by 99
The exploding worldwide cancer burden
Wilson, C. M., Tobin, S., & Young, R. C. (2004) · International Journal of Gynecological Cancer · doi:10.1111/j.1048-891x.2004.14178.x · Cited by 98
Molecular mechanisms of metastasis in prostate cancer
Clarke, N. W., Hart, C. A., & Brown, M. D. (2008) · Asian Journal of Andrology · doi:10.1038/aja.2008.29 · Cited by 98
Singh, R. P., Tyagi, A., Sharma, G. D., Mohan, S., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1565 · Cited by 97
Self-citationRaina, K., Rajamanickam, S., Singh, R. P., Deep, G., Chittezhath, M., & Agarwal, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1332 · Cited by 96
Self-citationSingh, R. P., Raina, K., Deep, G., Chan, D. C. F., & Agarwal, R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1846 · Cited by 96
Self-citationChemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
Rajamanickam, S., Balaiya, V., Kaur, M., Singh, R. P., & Agarwal, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3249 · Cited by 92
Self-citationKim, S., Choi, J. H., Lim, H. I., Lee, S.-K., Kim, W. W., Kim, J. S., Kim, J., Choe, J., Yang, J., Nam, S. J., et al. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.11.006 · Cited by 90
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells
Tyagi, A., Bhatia, N., Condon, M. S., Bosland, M. C., Agarwal, C., & Agarwal, R. (2002) · The Prostate · doi:10.1002/pros.10146 · Cited by 89
Self-citationLi, L., Gao, Y., Zhang, L., Zeng, J., He, D., & Sun, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.033 · Cited by 89
Kaur, M., Balaiya, V., Tyagi, A., Deep, G., Katiyar, S., Agarwal, C., & Agarwal, R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0304 · Cited by 87
Self-citationDhanalakshmi, S., Agarwal, P., Glodé, L. M., & Agarwal, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11299 · Cited by 85
Self-citationA Role for JNK-Paxillin Signaling in Cell Migration
Huang, C., Jacobson, K. A., & Schaller, M. D. (2004) · Cell Cycle · doi:10.4161/cc.3.1.601 · Cited by 84
Mokhtari, M. J., Motamed, N., & Shokrgozar, M. A. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.03.019 · Cited by 84
He (2010) · Oncology Reports · doi:10.3892/or_00000794 · Cited by 81
Gallo, D., Giacomelli, S., Ferlini, C., Raspaglio, G., Apollonio, P., Prislei, S., Riva, A., Morazzoni, P., Bombardelli, E., & Scambia, G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00624-5 · Cited by 80
Targeting silibinin in the antiproliferative pathway
Li, L., Zeng, J., Gao, Y., & He, D. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903533631 · Cited by 76
Flavonolignans from Silybum marianum moderate UVA-induced oxidative damage to HaCaT keratinocytes
Svobodová, A. R., Zdařilová, A., Walterová, D., & Vostálová, J. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.06.008 · Cited by 75
Chittezhath, M., Deep, G., Singh, R. P., Agarwal, C., & Agarwal, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0256 · Cited by 74
Self-citationMomeny, M., Khorramizadeh, M. R., Ghaffari, S. H., Yousefi, M., Yekaninejad, M. S., Esmaeili, R., Jahanshiri, Z., & Noori–Daloii, M. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.011 · Cited by 72
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft
Singh, R. P., Deep, G., Blouin, M., Pollak, M., & Agarwal, R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm218 · Cited by 72
Self-citationBhatia, N., Agarwal, C., & Agarwal, R. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_20 · Cited by 71
Self-citationKim, K. W., Choi, C. H., Kim, T. H., Kwon, C. H., Woo, J. S., & Kim, Y. K. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9935-6 · Cited by 71
Deep, G., Oberlies, N. H., Kroll, D. J., & Agarwal, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23485 · Cited by 71
Self-citationClinical trials of natural products as chemopreventive agents for prostate cancer
Bemis, D. L., Katz, A. E., & Buttyan, R. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.10.1191 · Cited by 71
Thelen, P., Wuttke, W., Jarry, H., Grzmil, M., & Ringert, R. H. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000121329.37206.1b · Cited by 70
Dhanalakshmi, S., Gu, M., Singh, R. P., & Agarwal, R. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg188 · Cited by 70
Self-citationGharagozloo, M., Khoshdel, Z., & Amirghofran, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.059 · Cited by 67
Dhanalakshmi, S., Agarwal, C., Singh, R. P., & Agarwal, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414640200 · Cited by 67
Self-citationTyagi, A., Agarwal, C., & Agarwal, R. (2002) · PubMed · Cited by 66
Self-citationSharma, Y., Agarwal, C., Singh, A. K., & Agarwal, R. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1032 · Cited by 65
Self-citationFlaig, T. W., Su, L., Harrison, G. S., Agarwal, R., & Glodé, L. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22465 · Cited by 65
Self-citationKim, S., Kim, S. H., Hur, S. M., Lee, S.-K., Kim, W. W., Kim, J. S., Kim, J., Choe, J., Nam, S. J., Lee, J. E., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.032 · Cited by 63
Tyagi, A., Raina, K., Singh, R. P., Gu, M., Agarwal, C., Harrison, G. S., Glodé, L. M., & Agarwal, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2006 · Cited by 63
Self-citationMolecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-07-0234 · Cited by 62
Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice
Cui, W., Gu, F., & Hu, K. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1943 · Cited by 62
Gu, M., Dhanalakshmi, S., Singh, R. P., & Agarwal, R. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0664 · Cited by 61
Self-citationSignificantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin
Huber, A., Thongphasuk, P., Erben, G., Lehmann, W., Tuma, S., Stremmel, W., & Chamulitrat, W. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.012 · Cited by 59
Provinciali, M., Papalini, F., Orlando, F., Pierpaoli, S., Donnini, A., Morazzoni, P., Riva, A., & Smorlesi, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2601 · Cited by 57
Therapeutic options for hormone-refractory prostate cancer in 2007
Hadaschik, B. A., & Gleave, M. E. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.05.010 · Cited by 57
Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)
Li, X., & Wu, J. (2010) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489210790936234 · Cited by 56
Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
Li-guang, Z., Liu, P., Chen, B., Wang, Y., Wang, X., Chiriva‐Internati, M., Wachtel, M. S., & Frezza, E. E. (2008) · PubMed · Cited by 54
Brandon‐Warner, E., Sugg, J. A., Schrum, L. W., & McKillop, I. H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.004 · Cited by 52
Natural Products for Chemopreventive and Adjunctive Therapy in Oncologic Disease
Dennis, T., Fanous, M. J., & Mousa, S. A. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825530 · Cited by 49
Efficacy of Deguelin and Silibinin on Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice
Yan, Y., Wang, Y., Tan, Q., Lubet, R. A., & You, M. (2005) · Neoplasia · doi:10.1593/neo.05532 · Cited by 49
Jung, H.-J., Park, J., Lee, J. S., Lee, S., Jang, B., Suh, S., Suh, M., & Baek, W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.068 · Cited by 49
Wang, H., Tashiro, S., Onodera, S., & Ikejima, T. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08054fp · Cited by 47
Raina, K., Serkova, N. J., & Agarwal, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0096 · Cited by 47
Self-citationMohan, S., Dhanalakshmi, S., Gu, M., Singh, R. P., & Agarwal, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.153 · Cited by 46
Self-citationNagarajan, S., Aranganathan, S., & Nalini, N. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9237-5 · Cited by 46
Silibinin Inhibits Angiogenesis via Flt-1, but not KDR, Receptor Up-Regulation1
Yang, S., Lin, J.-K., Huang, C., Chen, W., Li, S.-Y., & Chiu, J. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2005.04.042 · Cited by 45
Verschoyle, R. D., Greaves, P., Patel, K. R., Marsden, D. A., Brown, K., Steward, W. P., & Gescher, A. J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.020 · Cited by 43
Proteolysis and invasiveness of brain tumors: Role of urokinase-type plasminogen activator receptor
Mohanam, S., Sawaya, R. A., Yamamoto, M., Bruner, J. M., Nicholson, G. L., & Rao, J. S. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052890 · Cited by 41
Wu (2010) · Oncology Reports · doi:10.3892/or_00000797 · Cited by 41
Silibinin inhibits translation initiation: implications for anticancer therapy
Lin, C., Sukarieh, R., & Pelletier, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1152 · Cited by 40
Influence of diet on metastasis and tumor dormancy
Chambers, A. F. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9164-4 · Cited by 39
Silibinin Inhibits Osteoclast Differentiation Mediated by TNF Family Members
Kim, J. H., Kim, K., Jin, H. M., Song, I., Youn, B. U., Lee, J., & Kim, N. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0123-y · Cited by 39
Singh, R. P., Dhanalakshmi, S., Mohan, S., Agarwal, C., & Agarwal, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0478 · Cited by 39
Self-citationMomeny, M., Malehmir, M., Zaki‐Dizaji, M., Ghasemi, R., Ghadimi, H., Shokrgozar, M. A., Emami, A. H., Nafissi, S., Ghavamzadeh, A., & Ghaffari, S. H. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283340cd7 · Cited by 38
Deep, G., Raina, K., Singh, R. P., Oberlies, N. H., Kroll, D. J., & Agarwal, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23879 · Cited by 38
Self-citationRajamanickam, S., Kaur, M., Balaiya, V., Singh, R. P., & Agarwal, R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9968-1 · Cited by 37
Self-citationMohanam, S. (1999) · Frontiers in bioscience · doi:10.2741/mohanam · Cited by 36
Rainone, F. (2005) · PubMed · Cited by 36
Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells
Wang, H., Wei, X., Jiang, Y., Huang, H., Yang, Y., Fan, S., Zang, L., Tashiro, S., Onodera, S., & Ikejima, T. (2010) · Free Radical Research · doi:10.3109/10715761003692495 · Cited by 28
Tyagi, A., Sharma, Y., Agarwal, C., & Agarwal, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9545-z · Cited by 28
Self-citationSilibinin suppresses CD44 expression in prostate cancer cells.
Handorean, A. M., Yang, K., Robbins, E. W., Flaig, T. W., & Iczkowski, K. A. (2009) · PubMed · Cited by 27
Tumour invasion and metastasis: challenges facing drug discovery
Elvin, P., & GARNER, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.02.008 · Cited by 27
Nagarajan, S., Felix, A. J. W., & Nalini, N. (2009) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32832d1b4f · Cited by 26
Gu, M., Singh, R. P., Dhanalakshmi, S., Mohan, S., & Agarwal, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0052 · Cited by 23
Self-citationVerschoyle, R. D., Brown, K., Steward, W. P., & Gescher, A. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0611-8 · Cited by 11
Cited by
He, Q., & Shi, J. (2014) · Advanced Materials · doi:10.1002/adma.201303123 · Cited by 482
Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M., & Abreu, J. G. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.003 · Cited by 125
Metadata
- Authors
- Deep, G., & Agarwal, R.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2010-08-17
- Volume
- 29
- Issue
- 3
- Pages
- 447-463
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1965025928
- Cited by
- 253
- References
- 188
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.